JPMorgan Chase & Co. Increases Victrex (LON:VCT) Price Target to GBX 2,580

Victrex (LON:VCT) had its price objective lifted by stock analysts at JPMorgan Chase & Co. from GBX 2,250 ($31.60) to GBX 2,580 ($36.23) in a report issued on Monday, January 8th. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s target price points to a potential upside of 4.48% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Liberum Capital boosted their price objective on Victrex from GBX 2,440 ($34.26) to GBX 2,770 ($38.90) and gave the company a “buy” rating in a report on Monday, December 11th. Berenberg Bank reiterated a “buy” rating and issued a GBX 2,600 ($36.51) price objective on shares of Victrex in a report on Tuesday, December 5th. Barclays cut their price objective on Victrex from GBX 2,350 ($33.00) to GBX 2,270 ($31.88) and set an “equal weight” rating on the stock in a report on Tuesday, November 28th. Deutsche Bank reiterated a “hold” rating and issued a GBX 2,200 ($30.89) price objective on shares of Victrex in a report on Thursday, January 4th. Finally, Peel Hunt downgraded Victrex to a “hold” rating and set a GBX 2,300 ($32.30) price target on the stock. in a report on Tuesday, October 31st. Eight analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Victrex has an average rating of “Hold” and a consensus price target of GBX 2,309.80 ($32.44).

Victrex (VCT) opened at GBX 2,469.32 ($34.68) on Monday. The company has a market capitalization of $2,200.00 and a price-to-earnings ratio of 2,128.72. Victrex has a 12 month low of GBX 1,826 ($25.64) and a 12 month high of GBX 2,772 ($38.93).

In other news, insider Martin Court sold 441 shares of the stock in a transaction dated Friday, December 15th. The stock was sold at an average price of GBX 2,618 ($36.76), for a total value of £11,545.38 ($16,213.14). In the last quarter, insiders bought 14 shares of company stock worth $36,018.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at

Victrex Company Profile

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with's FREE daily email newsletter.

Leave a Reply